<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Pre-treatment <z:e sem="disease" ids="C0041364" disease_type="Disease or Syndrome" abbrv="">tumour lysis syndrome</z:e> (pre-TTLS) is not an unusual clinical entity in high-grade <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and lymphoblastic <z:mpath ids='MPATH_336'>leukaemias</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>The overall incidence and frequency is unknown and to the best of our knowledge none has been published in Nigeria involving adult females with advanced stage Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (ASBL) </plain></SENT>
<SENT sid="2" pm="."><plain>Three of the reported cases had pre-TTLS complicated by <z:hpo ids='HP_0001919'>acute renal failure</z:hpo> (ARF) </plain></SENT>
<SENT sid="3" pm="."><plain>The first two cases had a complete reversal of the ARF with aggressive supportive management and slow introduction of cytotoxic chemotherapy whereas the third case died of ARF due to delay in commencement of aggressive supportive management, chemotherapy and haemodialysis due to financial constraint </plain></SENT>
<SENT sid="4" pm="."><plain>This paper stresses the importance of aggressive supportive management and slow introduction of cytotoxic chemotherapy in patients with a stage C and/or stage D Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> presenting with pre-TTLS </plain></SENT>
</text></document>